It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The failure of vitamin C supplementation to reduce the incidence of colds in the general population indicates that routine prophylaxis is not justified. Vitamin C could be useful for people exposed to brief periods of severe physical exercise. While the prophylaxis trials have consistently shown that vitamin C reduces the duration and alleviates the symptoms of colds, this was not replicated in the few therapeutic trials that have been carried out. Further therapeutic RCTs are warranted.
Originally posted by NoJoker13
reply to post by Julie Washington
Backing up your information, that vitamin C actually does what you and others are claiming it to do. Basically a source to substantiate the information you've provided such as like another poster posted a review from cochrane. I'm looking for credible scientists who have evaluated and reviewed this information, if this is as 'great' as it's supposed to be I'm sure you could find me a .org source or at least a scientific journal of high regard.edit on 14-1-2013 by NoJoker13 because: (no reason given)edit on 14-1-2013 by NoJoker13 because: (no reason given)
Moreover, a regimen of daily pharmacologic ascorbate treatment significantly decreased growth rates of ovarian (P < 0.005), pancreatic (P < 0.05), and glioblastoma (P < 0.001) tumors established in mice.
Similar pharmacologic concentrations were readily achieved in humans given ascorbate intravenously.
These data suggest that ascorbate as a prodrug may have benefits in cancers with poor prognosis and limited therapeutic options.
A Japanese study on vitamin C and colds was published in 2006 in the European Journal of Clinical Nutrition. This study was a five-year, randomized, double-blind (but not placebo-controlled) trial designed to evaluate the effect of a daily dose of 50 mg or 500 mg of vitamin C on the development of gastric cancer among 244 subjects. (The 50-mg dose of vitamin C served as a quasi-placebo.)
The researchers evaluated the effects of the vitamin C supplements on the common cold at the completion of the study.
The risk of contracting three or more colds in the five-year period was decreased by 66% by the daily intake of the 500-mg vitamin C supplement.
Disease Prevention
The amount of vitamin C required to prevent chronic disease appears to be more than that required for prevention of scurvy. Much of the information regarding vitamin C and the prevention of chronic disease is based on prospective studies, in which vitamin C intake is assessed in large numbers of people who are followed over time to determine whether they develop specific chronic diseases.
Originally posted by DevolutionEvolvd
reply to post by Julie Washington
And can you provide a link to the second quote you provided in the previous post of yours?
OBJECTIVE:
To study the effect of megadose Vitamin C in preventing and relieving cold and flu symptoms in a test group compared with a control group.
SUBJECTS:
A total of 463 students ranging in age from 18 to 32 years made up the control group. A total of 252 students ranging in age from 18 to 30 years made up the experimental or test group.
METHOD:
Investigators tracked the number of reports of cold and flu symptoms among the 1991 test population of the facility compared with the reports of like symptoms among the 1990 control population. Those in the control population reporting symptoms were treated with pain relievers and decongestants, whereas those in the test population reporting symptoms were treated with hourly doses of 1000 mg of Vitamin C for the first 6 hours and then 3 times daily thereafter. Those not reporting symptoms in the test group were also administered 1000-mg doses 3 times daily.
RESULTS:
Overall, reported flu and cold symptoms in the test group decreased 85% compared with the control group after the administration of megadose Vitamin C.
CONCLUSION:
Vitamin C in megadoses administered before or after the appearance of cold and flu symptoms relieved and prevented the symptoms in the test population compared with the control group.
Originally posted by DevolutionEvolvd
reply to post by Julie Washington
And can you provide a link to the second quote you provided in the previous post of yours?
A Japanese study on vitamin C and colds was published in 2006 in the European Journal of Clinical Nutrition. This study was a five-year, randomized, double-blind (but not placebo-controlled) trial designed to evaluate the effect of a daily dose of 50 mg or 500 mg of vitamin C on the development of gastric cancer among 244 subjects. (The 50-mg dose of vitamin C served as a quasi-placebo.) The researchers evaluated the effects of the vitamin C supplements on the common cold at the completion of the study. The risk of contracting three or more colds in the five-year period was decreased by 66% by the daily intake of the 500-mg vitamin C supplement. There was little difference in severity or duration of colds between subjects in the low-dose or high-dose groups. This study deserves special mention because it was much longer (five years) than the trials reported by Hemila and covered many cold seasons in which subjects were probably exposed repeatedly to many cold viruses.
We are an independent, not-for-profit organisation, funded by a variety of sources including governments, universities, hospital trusts, charities and personal donations.
We do not accept commercial or conflicted funding – this is vital for us to generate authoritative and reliable information, produced by people who can work freely, unconstrained by commercial and financial interests.
Cochrane Reviews are unique because they are both produced by, and are relevant to, everyone interested in the effects of human health care. Based on the best available evidence, healthcare providers can decide if they should fund production of a particular drug. Practitioners can find out if an intervention is effective in a specific clinical context. Patients and other healthcare consumers can assess the potential risks and benefits of their treatment.
Our work is internationally recognised as the benchmark for high quality information about the effectiveness of health care.
Twenty-nine trial comparisons involving 11,306 participants contributed to the meta-analysis on the risk ratio (RR) of developing a cold whilst taking prophylactic vitamin C. In the general community trials, involving 10,708 participants, the pooled RR was 0.97 (95% confidence interval (CI) 0.94 to 1.00). Five trials involving a total of 598 marathon runners, skiers and soldiers on subarctic exercises yielded a pooled RR of 0.48 (95% CI 0.35 to 0.64).
Twenty-nine comparisons examined the effect of prophylactic vitamin C on common cold duration (9649 episodes). In adults the duration of colds was reduced by 8% (3% to 12%), and in children by 13% (6% to 21%). The severity of colds was significantly reduced in the prophylaxis trials.
Seven trial comparisons examined the effect of therapeutic vitamin C (3249 episodes). No consistent differences from the placebo group were seen in the duration or severity of colds.
We excluded trials if a dose less than 0.2 g per day of vitamin C was used, or if there was no placebo comparison. We did not restrict to randomised controlled trials (RCTs).
We excluded trials if a dose less than 0.2 g per day of vitamin C was used, or if there was no placebo comparison. We did not restrict to randomised controlled trials (RCTs).
Trials of high doses of vitamin C administered therapeutically, starting after the onset of symptoms, showed no consistent effect on either duration or severity of common cold symptoms. However, only a few therapeutic trials have been carried out, and none have examined children, although the effect of prophylactic vitamin C has been greater in children.
One large trial with adults reported equivocal benefit from an 8 g therapeutic dose at the onset of symptoms, and two trials using five-day supplementation reported benefit.
More trials are necessary to settle the possible role of therapeutic vitamin C, meaning administration immediately after the onset of symptoms.
Overall, the results of the five identified trials suggested vitamin C is beneficial in both preventing and treating pneumonia. However, these trials were carried out in such extraordinary conditions that the results may not apply to the general population. Therefore, more research is needed. In the meantime, supplementing pneumonia patients who have low plasma vitamin C levels may be reasonable because of its safety and low cost.
If so, why haven't you heard more about it? Why haven't more doctors used vitamin C as medicine?
Progress takes time. Fresh fruit was known to cure scurvy by 1753, yet governments ignored the fact for nearly 100 years. Countless thousands died in the meantime. The 19th century doctor who first advocated washing one's hands between patients died ignored and in disgrace with the medical profession. The toxic metal mercury was used as medicine into the twentieth century.
The first physician to aggressively use vitamin C to cure disease was Frederick R. Klenner, MD, beginning back in the early 1940's. Dr. Klenner successfully treated chicken pox, measles, mumps, tetanus and polio with huge doses of the vitamin.
The following is a complete list of the conditions that Dr. Klenner found that responded to extremely high dose vitamin C therapy:
Pneumonia
Encephalitis
Herpes Zoster (shingles)
Herpes Simplex
Mononucleosis
Pancreatitis
Hepatitis
Rocky Mountain Spotted Fever
Bladder Infection
Alcoholism
Arthritis
Some Cancers
Leukemia
Atherosclerosis
Ruptured Intervertebral Disc
High Cholesterol
Corneal Ulcer
Diabetes
Glaucoma
Schizophrenia
Burns and secondary infections
Heat Stroke
Radiation Burns
Heavy Metal Poisoning (Mercury, Lead)
Venomous Bites
Multiple Sclerosis
Chronic Fatigue
Complications of Surgery
This seems like an impossibly long list.
At this point, one can either dismiss the subject or investigate further.
Dr. Klenner chose to investigate.
The result? He used massive doses of vitamin C for over forty years of family practice. He wrote two dozen medical papers on the subject. (1) It is difficult to ignore his success, but it has been done. Dr. Klenner wrote: "Some physicians would stand by and see their patient die rather than use ascorbic acid (vitamin C) because in their finite minds it exists only as a vitamin."
Originally posted by miss_sky
reply to post by Julie Washington
Julie,
Thank you for your kind response. I have finally ordered liposomal and vitamin b3 niacin off Amazon and I'm just waiting for it to get here. Yes I did watch the vid on b3, I researched in thevitamins helping with depression but I got the flush free kind, so that's prob why my results weren't so great. if this really works with my depression and anxiety, hopefully I can get off the prescribed stuff, which has always been my goal. I will def be back on this thread to report my results.edit on 22-1-2013 by miss_sky because: type os